Search for: "BM"
Results 81 - 100
of 430
Sorted by Relevance
|
Sort by Date
12 Apr 2021, 2:30 pm
APRIL 1, 2021, The United States Department of Justice settled a case against Bristol-Myers Squibb (“BMS”), a global biopharmaceutical company. [read post]
18 Nov 2019, 9:00 pm
It finds, contrary to many commenters, that a large supermajority of cases reject the argument that BMS’s constraints apply with respect to unnamed plaintiff class members. [read post]
13 Apr 2015, 3:00 am
Food and Drug Administration approved the use of BMS’s immunotherapy drug Opvido for the treatment of lung cancer. [read post]
25 May 2023, 1:24 am
Jane LambertCourt of Appeal (Lord Justices Arnold, Nugee and Warby) Sandoz Ltd v Bristol-Myers Squibb Holdings Ireland Unlimited Company[2023] EWCA Civ 472 (4 May 2023)This was an appeal by Bristol Myers Squibb Ireland ("BMS") against Mr Justice Meade's judgment in Sandoz Ltd and another v Bristol-Myers Squibb Holdings Ireland (Unlimited) Company [2022] EWHC 822 (Pat) (7 April 2022) which I [read post]
14 Oct 2022, 9:42 am
Baltimore Medical System (BMS), the largest Federally Qualified Health Center (FQHC) system in Maryland, reached an agreement with the proposed school of Maryland College of Osteopathic Medicine at Morgan State University to serve as the school’s community health clinical teaching arm. [read post]
22 Oct 2014, 9:04 am
" At the "Patently-O" blog, Dennis Crouch has a post that begins, "The Federal Circuit has rejected BMS's petition for en banc rehearing in its chemical compound obviousness case. [read post]
28 Aug 2022, 3:53 pm
The patent was held by Bristol-Myers Squib Holdings Ireland (Unlimited) Company ("BMS") and the proceedings were brought by [read post]
4 Nov 2010, 9:59 pm
By James DeGiulio -- Sanofi and BMS Awarded $442M in Plavix Patent Suit Apotex has been ordered to pay $442.2 million in damages to sanofi-aventis and Bristol-Myers Squibb Co. for infringing their patent covering the blood thinner Plavix. [read post]
12 Jan 2019, 10:12 am
On January 11, 2019, Congressman Peter Welch and Francis Rooney, members of Congress, wrote a letter to the Federal Trade Commission (“FTC”), urging the Commission to investigate Bristol-Myers Squibb’s (“BMS”) acquisition of Celgene. [read post]
12 Apr 2012, 4:54 am
BM-patented floor could detect a heart attack, call the cops http://zite.to/HxKHcb 38% of Children on Facebook Are Younger Than 12 http://zite.to/HCe09v Microsoft Gets Legal Reprieve in Patent Dispute With Motorola http://zite.to/Htzepf Canada | CFIA developing online self-assessment tool for label compliance, remove food container size restrictions http://bit.ly/Htyr7D Latest amendments to Canadian trade-marks Wares & Services Manual focus on cloud computing, “smart”… [read post]
19 Nov 2011, 12:53 pm
From NAFSA: The Department of State (DoS) has recently identified difficulties with its Consolidated Consular Database (CCD) communicating with the Student and Exchange Visitor Program’s (SEVP) Student and Exchange Visitor Information System (SEVIS). http://www.nafsa.org/uploadedFiles/BM%201111-02%20DoS%20Not%20Issuing%20F%20M%20or%20J%20Visas.pdf DoS discovered this issue on November 14, 2011. [read post]
21 Nov 2010, 9:02 pm
Bristol-Myers Squibb Co. 2:10-cv-00497; filed November 18, 2010 in the Eastern District of Texas False marking based on BMS' marking of its Cefzil products, its Buspar products, and its Pravachol products U.S. [read post]
6 Apr 2011, 2:17 am
Court of Appeal (Civil Division) Makisi v Birmingham City Council [2011] EWCA Civ 355 (31 March 2011) BM v Secretary of State for the Home Department [2011] EWCA Civ 366 (05 April 2011) High Court (Queen’s Bench Division) Le Breton v Petrpodel Resources Ltd [2011] EWHC 769 (QB) (01 April 2011) High Court (Chancery Division) JSC BTA Bank v Solodchenko & Ors [2011] EWHC 843 (Ch) (05 April 2011) High Court (Administrative Court) Panesar (t/a Anami Law), R (on the application of) v… [read post]
4 Jan 2019, 9:16 pm
The COMP asked BMS to demonstrate the significant benefit of Empliciti over Kyprolis. [read post]
25 Jan 2017, 7:38 am
Law360 reports that Bristol-Myers Squibb and Pfizer are facing a $10 million suit for failing to disclose the risks of their Eliquis blood thinner. [read post]
5 Aug 2013, 9:59 pm
The UK High Court recently gave its judgment in the case of Merck, Sharp & Dohme Corp. and Bristol-Myers Squibb Pharmaceuticals Ltd (collectively referred to in the judgement as BMS) v Teva Pharma B.V. and Teva UK Ltd (Teva) (decision). [read post]
7 Apr 2010, 9:44 am
The BMS case highlights the need for clear and unambiguous drafting in licence agreements (and in any amendments to licence agreements). [read post]
Will New Black Box Warning About Heart Attacks Lead GlaxoSmithKline To Withdraw Avandia From Market?
9 Nov 2007, 9:03 am
In turn, GlaxoSmithKline could follow the lead of Bristol-Myers Squibb (BMS) when that drug company experienced increasing scrutiny about the safety of its antibiotic Tequin in 2006. [read post]
26 Apr 2017, 7:49 am
Yesterday the Supreme Court held oral arguments in a personal jurisdiction case involving purchasers of the drug Plavix who bought the drug in Ohio but wanted to join a suit in California where the company does almost 1 billion dollars... [read post]
15 Dec 2008, 9:51 pm
RELATED READING: Sanofi/BMS press release Apotex press release Bloomberg article Previous OBB posts: 8/8/06 (Apotex launches at-risk); 12/10/06 (Fed. [read post]
